Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy

From - Diagnostic Testing & Emerging Technologies
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here